Abstract
The complete nucleotide sequence of genome segment 4 from the human group C rotavirus (Bristol strain) was determined. Comparison of the nucleotide sequences of the genome termini with the consensus 5′ and 3′ terminal non-coding sequences of the human group C rotavirus genome revealed characteristic 5′ and 3′ sequence motifs. Human group C rotavirus genome segment 4 is 2, 166bp long and encodes a single open reading frame of 2,082 nucleotides (693 amino acids) starting at nucleotide 55 and terminating at nucleotide 2,136 giving a 3′ untranslated region of 30 nucleotides. Alignment with the porcine group C VP3 equivalent gene showed the human gene is one amino acid longer, and that the proteins have 84.1% amino acid sequence identity. A conserved potential nucleotide binding motif shared with the porcine VP3 sequence was identified. Analogy with the group A rotaviruses suggested that the genome segment 4 encodes the group C rotavirus guanylyltransferase.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
EstesM.K. and CohenJ.C., Microbiol Rev53, 410–449, 1989
PrasadB.V.V. and ChiuW. in RamigR.F. (ed)Rotaviruses, Current Topics in Microbiology and Immunology, vol 185, Springer-Verlag, Berlin pp 9–29, 1994.
MitchellD.B. and BothG.W., Nucleic Acids Res.16, 624, 1988.
MitchellD.B. and BothG.W. Virology177, 324–331, 1990.
SaifL.J. and JiangB. in RamigR.F. (ed)Rotaviruses, Current Topics in Microbiology and Immunology, vol 185, Springer-Verlag, Berlin pp 339–371, 1994.
HungT., ChenG., WangC., ChouZ., ChaoT., YeW., YaoH., and MengK., Lancet 2, 1078–1079, 1983.
LambdenP.R., CookeS.J., CaulE.O., and ClarkeI.N., J. Virol66, 1817–1822, 1992.
CaulE.O., AshleyC.R., DarvilleJ.M. and BridgerJ.C., J. Med Virol30, 201–205, 1990.
CookeS.J., LambdenP.R., CaulE.O., and ClarkeI.N., Virology184, 781–785, 1991.
LambdenP.R. and ClarkeI.N. in AdolphK.W. (ed) Methods in Molecular Genetics, Molecular Virology Techniques, Part B, Vol. 7. Academic Press, Orlando FL, 1995, Chapter 23.
FieldingP.A., LambdenP.R., CaulE.O., and ClarkeI.N., Virology204, 442–446, 1994.
BremontM. Juste-LesageP., Chabanne-VautherotD., CharpilienneA., and CohenJ., Virology186, 684–692, 1992.
KozakM., J. Biol Chem266, 19867–19870, 1991.
JiangJ.M., SaifL.J., KangS.Y. and KimJ.H., J. Virol64, 3171–3178, 1990.
GriceA.S., LambdenP.R., CaulE.O., and ClarkeI.N., J. Med Virol44, 166–171, 1994.
PizarroJ.L., SandinoA.M., PizarroJ.M., FernandezJ., and SpencerE., J. Gen Virol72, 325–332, 1991.
LiuM., MattionN.M., and EstesM.K., Virology188, 77–84, 1992.
GorbalenyaA.E. and KooninE.V., Nucleic Acids Res.17, 8413–8440, 1989.
ClevelandD.R., ZarblH., and MillwardS., J. Virol60, 307–311, 1986.
SeligerL.S., ZhengK., and ShatkinA.J., J. Biol. Chem.,262, 16289–16293, 1987.
MaoZ. and JoklikW.K., Virology,185, 377–386, 1991.